DESCOVY®▼

(emtricitabine / tenofovir alafenamide)

DESCOVY® is a fixed-dose combination tablet containing emtricitabine (FTC) and tenofovir alafenamide (TAF). Together, they form a nucleoside reverse transcriptase inhibitor (NRTI) backbone.1,2